Huameng Li

1.2k total citations
19 papers, 946 citations indexed

About

Huameng Li is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Huameng Li has authored 19 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Huameng Li's work include Cytokine Signaling Pathways and Interactions (8 papers), Inflammatory mediators and NSAID effects (4 papers) and Computational Drug Discovery Methods (3 papers). Huameng Li is often cited by papers focused on Cytokine Signaling Pathways and Interactions (8 papers), Inflammatory mediators and NSAID effects (4 papers) and Computational Drug Discovery Methods (3 papers). Huameng Li collaborates with scholars based in United States, China and South Korea. Huameng Li's co-authors include Jiayuh Lin, Chenglong Li, Guang Liang, Shulin Yang, Chengguang Zhao, Huey‐Jen Lin, David Jou, Hui Xiao, Chenglong Li and Aiguo Liu and has published in prestigious journals such as PLoS ONE, PLANT PHYSIOLOGY and Cancer Research.

In The Last Decade

Huameng Li

18 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huameng Li United States 15 417 335 182 143 104 19 946
Clarissa Araújo Gurgel Rocha Brazil 22 491 1.2× 233 0.7× 135 0.7× 110 0.8× 59 0.6× 72 1.1k
Mohammad Sarwar Jamal Saudi Arabia 19 467 1.1× 203 0.6× 82 0.5× 130 0.9× 55 0.5× 37 992
Bilal Rah India 20 653 1.6× 238 0.7× 69 0.4× 125 0.9× 72 0.7× 47 1.2k
Astrid Kaiser Germany 21 729 1.7× 324 1.0× 57 0.3× 100 0.7× 51 0.5× 63 1.3k
Margaret M. Kasten United States 14 1.2k 2.9× 317 0.9× 151 0.8× 95 0.7× 84 0.8× 17 1.5k
Jinmei Jin China 17 584 1.4× 232 0.7× 57 0.3× 121 0.8× 48 0.5× 38 988
Nicole Doudican United States 18 582 1.4× 234 0.7× 46 0.3× 83 0.6× 56 0.5× 45 958
Ning Ji China 19 554 1.3× 396 1.2× 100 0.5× 60 0.4× 54 0.5× 51 984
Zhengduo Yang China 16 679 1.6× 522 1.6× 61 0.3× 104 0.7× 131 1.3× 30 1.3k

Countries citing papers authored by Huameng Li

Since Specialization
Citations

This map shows the geographic impact of Huameng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huameng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huameng Li more than expected).

Fields of papers citing papers by Huameng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huameng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huameng Li. The network helps show where Huameng Li may publish in the future.

Co-authorship network of co-authors of Huameng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Huameng Li. A scholar is included among the top collaborators of Huameng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huameng Li. Huameng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wei, Jia, Ling Ma, Ruijie Zhang, et al.. (2019). Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy. Journal of Experimental & Clinical Cancer Research. 38(1). 63–63. 50 indexed citations
2.
Xiao, Hui, Hemant K. Bid, Xiang Chen, et al.. (2017). Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy. PLoS ONE. 12(7). e0180297–e0180297. 36 indexed citations
3.
Wang, Yina, Haiyan Ma, Tianshu Liu, et al.. (2017). Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling. Oncotarget. 8(20). 33683–33693. 14 indexed citations
4.
Zhang, Yali, Dandan Liang, Lili Dong, et al.. (2015). Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury. Respiratory Research. 16(1). 43–43. 83 indexed citations
5.
Zhao, Chengguang, Huameng Li, Huey‐Jen Lin, et al.. (2015). Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism. Trends in Pharmacological Sciences. 37(1). 47–61. 198 indexed citations
6.
Zhao, Chenguang, Yali Zhang, Peng Zou, et al.. (2015). Synthesis and biological evaluation of a novel class of curcumin analogs as anti-inflammatory agents for prevention and treatment of sepsis in mouse model. Drug Design Development and Therapy. 9. 1663–1663. 28 indexed citations
7.
8.
Li, Huameng. (2012). Multiple Ligand Simultaneous Docking (MLSD) and Its Applications to Fragment Based Drug Design and Drug Repositioning. OhioLink ETD Center (Ohio Library and Information Network). 4 indexed citations
9.
Li, Lin, Huameng Li, Minghao Xu, et al.. (2012). Abstract 4772: Novel drug discovery approach targeting STAT3 for breast cancer therapy using MLSD and drug repositioning. Cancer Research. 72(8_Supplement). 4772–4772.
10.
Liu, Yan, Aiguo Liu, Huameng Li, Chenglong Li, & Jiayuh Lin. (2011). Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor–Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells. Cancer Prevention Research. 4(8). 1296–1305. 54 indexed citations
11.
Reed, Suzanne, Huameng Li, Chenglong Li, & Jiayuh Lin. (2011). Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells. Biochemical and Biophysical Research Communications. 407(3). 450–455. 26 indexed citations
12.
13.
Li, Huameng & Chenglong Li. (2010). Multiple ligand simultaneous docking: Orchestrated dancing of ligands in binding sites of protein. Journal of Computational Chemistry. 31(10). 2014–2022. 41 indexed citations
14.
Venu, R C, Yulin Jia, Malali Gowda, et al.. (2007). RL-SAGE and microarray analysis of the rice transcriptome after Rhizoctonia solani infection. Molecular Genetics and Genomics. 278(4). 421–431. 48 indexed citations
15.
Gowda, Malali, Huameng Li, & Guo‐Liang Wang. (2007). Robust analysis of 5′-transcript ends: a high-throughput protocol for characterization of sequence diversity of transcription start sites. Nature Protocols. 2(7). 1622–1632. 7 indexed citations
16.
Gowda, Malali, R C Venu, Huameng Li, et al.. (2007). Magnaporthe griseaInfection Triggers RNA Variation and Antisense Transcript Expression in Rice. PLANT PHYSIOLOGY. 144(1). 524–533. 23 indexed citations
17.
Gowda, Malali, R C Venu, Kan Nobuta, et al.. (2006). Deep and comparative analysis of the mycelium and appressorium transcriptomes of Magnaporthe grisea using MPSS, RL-SAGE, and oligoarray methods. BMC Genomics. 7(1). 310–310. 48 indexed citations
18.
Jantasuriyarat, Chatchawan, Malali Gowda, Guodong Lu, et al.. (2005). Large-Scale Identification of Expressed Sequence Tags Involved in Rice and Rice Blast Fungus Interaction. PLANT PHYSIOLOGY. 138(1). 105–115. 78 indexed citations
19.
Wasicak, James T., et al.. (1997). Alkylation of tricarbonyl(diene)iron complexes: Model studies for the preparation of protomycinolide IV. Tetrahedron. 53(12). 4185–4198. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clarissa Araújo Gurgel Rocha Breakdown of academic impact, for papers by Mohammad Sarwar Jamal Breakdown of academic impact, for papers by Bilal Rah Breakdown of academic impact, for papers by Astrid Kaiser Breakdown of academic impact, for papers by Margaret M. Kasten Breakdown of academic impact, for papers by Jinmei Jin Breakdown of academic impact, for papers by Nicole Doudican Breakdown of academic impact, for papers by Ning Ji Breakdown of academic impact, for papers by Zhengduo Yang
Rankless by CCL
2026